Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,142
Closed -$1.06M 949
2022
Q1
$1.06M Buy
+10,142
New +$1.19M 0.3% 85
2021
Q4
Sell
-9,073
Closed -$1.01M 998
2021
Q3
$1.01M Buy
9,073
+4,049
+81% +$475K 0.24% 87
2021
Q2
$622K Sell
5,024
-885
-15% -$104K 0.14% 142
2021
Q1
$699K Buy
5,909
+666
+13% +$82.5K 0.2% 111
2020
Q4
$572K Buy
5,243
+607
+13% +$57.6K 0.17% 125
2020
Q3
$376K Sell
4,636
-3,405
-42% -$259K 0.11% 161
2020
Q2
$456K Buy
8,041
+3,863
+92% +$204K 0.12% 147
2020
Q1
$200K Buy
4,178
+2,162
+107% +$118K 0.06% 198
2019
Q4
$118K Buy
+2,016
New +$107K 0.02% 303

Other funds holding TSM

Exane Derivatives's TSM Position: Q2 2022 in Review

Exane Derivatives sold out of TSMC (TSM) in Q2 2022, closing a stake of 10,142 shares — an estimated $1.06M sold.

Exane Derivatives first reported a position in TSM in Q4 2019 and held it in 9 quarters. The position peaked at $1.06M in Q1 2022. 1,376 funds tracked by Wall St. Rank hold TSM as of Q2 2022.

  • Exane Derivatives reported no remaining TSMC position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 10,142 TSMC shares in Q2 2022, an estimated $1.06M.
  • Exane Derivatives first reported a position in TSMC in Q4 2019 and held it in 9 quarters.
  • Exane Derivatives's TSMC position peaked at $1.06M in Q1 2022.
  • 1,376 funds tracked by Wall St. Rank held TSMC as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.